"Le Centre d’Accueil et de Soins Hospitaliers de Nanterre est un établissement public unique en France par son offre à la fois hospitalière et d’accueil et de soins pour les personnes sans-abris. Il dispose : - d’un pôle hospitalier (urgences et soins critiques, cardiologie, diabétologie, gériatrie, maternité, plateau de consultations, imagerie médicale et laboratoire) - d’activités médico-sociales (EHPAD et unité de soins de longue durée), - d’un pôle de médecine sociale assurant une mission d’hébergement et de prise en charge des personnes sans abri"

During the past decade, Hôpital Max Fourestier conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hôpital Max Fourestier" are "Community-acquired Pneumonia" (1 trials), "Eyelid Diseases" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Hôpital Max Fourestier" in a lesser frequency.

Most popular intervention types in "Hôpital Max Fourestier" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blephasteam" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Max Fourestier" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpital Max Fourestier". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hôpital Max Fourestier, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Max Fourestier, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".